Lexicon Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2015
Total Assets: $652.0M
Liabilities Breakdown FY2015
Total Liabilities: $366.1M
Asset Breakdown
Total Assets: $652.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $203.0M | 31.1% |
| Accounts Receivable | $911.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $21.2M | 3.3% |
| Goodwill | $44.5M | 6.8% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $382.3M | 58.6% |
Liabilities Breakdown
Total Liabilities: $366.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $19.7M | 5.4% |
| Long-Term Debt | $101.0M | 27.6% |
| Other Liabilities | $245.4M | 67.0% |